A new look at atrial fibrillation: Lessons learned from drugs, pacing, and ablation therapies

European Heart Journal

Volumn 34, Issue 35, 2013, Pages 2739-2745

  Kappenberger, Lukas ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Atrial fibrillation; Classifications; Electrocardiography; Electrophysiology; Research; Therapy

Indexed keywords

BIOLOGICAL MARKER;

DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; HEART ATRIUM FIBRILLATION; HUMAN; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW;

ATRIAL FIBRILLATION; CLASSIFICATIONS; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; RESEARCH; THERAPY;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FORECASTING; HUMANS;

EID: 84890070389     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht252     Document Type: Review

References (51)

1. Laennec RTH. De l'auscultation médiate, ou, Traité du diagnostic des maladies des poumons et du coeur fondé principalement sur ce nouveau moyen d'exploration. Tomes 1 et 2. J-A. Brosson et J-S. Chaudé, Libraires à Paris. http://gallica.bnf.fr/ark 12148/bpt6k987580/ and http://gallica.bnf.fr/ark:/12148/bpt6k98759b (14 January 2013); 1819
2. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Bauersachs R, Breithardt G. Incidence and prevalence of atrial fibrillation: An analysis based on 8.3 million patients. Europace 2013;15:486-493
3. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001;286:180-187
4. Magnani JW, Williamson MA, Ellinor PT, Monahan KM, Benjamin EJ. P wave indices: Current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol 2009;2:72-79
5. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-2429
6. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA III, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM, Fuster V, Ryden LE, Cannom DS, Le Heuzey JY, Crijns HJ, Olsson S, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Guyton RA, Tarkington LG, YancyCW. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm 2011;8:157-176
7. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GY, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Outcome parameters for trials in atrial fibrillation: Executive summary. Eur Heart J 2007;28: 2803-2817
8. Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner MF, Van Gelder IC, Ellinor PT, Benjamin EJ. Symptoms and functional status of patients with atrial fibrillation: State of the art and future research opportunities. Circulation 2012;125: 2933-2943
9. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: A translational appraisal. Physiol Rev 2011;91:265-325
10. Kirchhof P, LipGY, Van Gelder IC, Bax J, Hylek E, Kaab S, Schotten U, Wegscheider K, Boriani G, Brandes A, Ezekowitz M, Diener H, Haegeli L, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Aunes-Jansson M, Blomstrom-Lundqvist C, Borentain M, Breitenstein S, Brueckmann M, Cater N, Clemens A, Dobrev D, Dubner S, Edvardsson NG, Friberg L, Goette A, Gulizia M, Hatala R, Horwood J, Szumowski L, Kappenberger L, Kautzner J, Leute A, Lobban T, Meyer R, Millerhagen J, Morgan J, Muenzel F, Nabauer M, Baertels C, Oeff M, Paar D, Polifka J, Ravens U, Rosin L, Stegink W, Steinbeck G, Vardas P, Vincent A, Walter M, Breithardt G, Camm AJ. Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options-A report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace 2012;14:8-27
11. Arora R. Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: Implications for therapies targeting the atrial autonomic nervous system. Circ Arrhythm Electrophysiol 2012;5:850-859
12. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339: 659-666
13. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997;96:3710-3720
14. Haissaguerre M, Marcus FI, Fischer B, Clementy J. Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: Report of three cases. J Cardiovasc Electrophysiol 1994;5:743-751
15. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 1997;96:1686-1695
16. Smit MD, Maass AH, De Jong AM, Muller Kobold AC, Van Veldhuisen DJ, Van Gelder IC. Role of inflammation in early atrial fibrillation recurrence. Europace 2012;14:810-817
17. Chimenti C, Russo MA, Carpi A, Frustaci A. Histological substrate of human atrial fibrillation. Biomed Pharmacother 2010;64:177-183
18. Kalman JM, Kumar S, Sanders P. Markers of collagen synthesis, atrial fibrosis, and the mechanisms underlying atrial fibrillation. J Am Coll Cardiol 2012;60:1807-1808
19. Calo L, Martino A. Insidious coronary artery disease: Cause, consequence, or innocent bystander for idiopathic atrial fibrillation? Heart Rhythm 2012;9:1930-1931
20. Sandberg F, Bollmann A, Husser D, Stridh M, Sornmo L. Circadian variation in dominant atrial fibrillation frequency in persistent atrial fibrillation. Physiol Meas 2010;31: 531-542
21. Eckstein J, Maesen B, Linz D, Zeemering S, van Hunnik A, Verheule S, Allessie M, Schotten U. Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat. Cardiovasc Res 2011;89:816-824
22. JacquemetV, Kappenberger L, Henriquez CS.Modeling atrial arrhythmias: Impact on clinical diagnosis and therapies. IEEE Rev Biomed Eng 2008;1:94-114.
23. Morganroth J, Horowitz LN, Josephson ME, Kastor JA. Relationship of atrial fibrillatory wave amplitude to left atrial size and etiology of heart disease. An old generalization re-examined. Am Heart J 1979;97:184-186
24. Abacherli R, Leber R, Lemay M, Vesin JM, van Oosterom A, Schmid HJ, Kappenberger L. Development of a toolbox for electrocardiogram-based interpretation of atrial fibrillation. J Electrocardiol 2009;42:517-521
25. Uldry L, Van Zaen J, PrudatY, Kappenberger L, Vesin JM. Measures of spatiotemporal organization differentiate persistent from long-standing atrial fibrillation. Europace 2012;14:1125-1131
26. Schotten U, Maesen B, Zeemering S. The need for standardization of time-And frequency-domain analysis of body surface electrocardiograms for assessment of the atrial fibrillation substrate. Europace 2012;14:1072-1075
27. Vaughan Williams EM. Classification of antidysrhythmic drugs. Pharmacol Ther B 1975;1:115-138
28. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-788
29. Kirchhof P, Andresen D, Bosch R, Borggrefe M, Meinertz T, Parade U, Ravens U, Samol A, Steinbeck G, Treszl A, Wegscheider K, Breithardt G. Short-Term versus long-Term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): A prospective, randomised, open-label, blinded endpoint assessment trial. Lancet 2012;380:238-246
30. Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J. Twenty-five years in the making: Flecainide is safe and effective for the management of atrial fibrillation. Europace 2011; 13:161-173
31. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, RosenbergY, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. A comparison of rate control and rhythm control in patients with atrial fibrillation.NEngl J Med 2002;347:1825-1833
32. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-1513
33. Le Heuzey JY, Marijon E, LavergneT, Otmani A. Management of ventricular and atrial arrhythmias in humans: Towards a patient-specific approach. Europace 2012; 14(Suppl. 5):v125-v128
34. Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. JAMA 1962;182:548-555
35. Levy S, Lauribe P, Dolla E, Kou W, Kadish A, Calkins H, Pagannelli F, Moyal C, Bremondy M, Schork A. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992;86:1415-1420
36. Wellens HJ, Lau CP, Luderitz B, Akhtar M, Waldo AL, Camm AJ, Timmermans C, TseHF, JungW, Jordaens L, Ayers G. Atrioverter: An implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651-1656
37. Uldry L, Virag N, Lindemans F, Vesin JM, Kappenberger L. Atrial septal pacing for the termination of atrial fibrillation: Study in a biophysical model of human atria. Europace 2012;14(Suppl. 5):v112-v120
38. Barold SS, Wyndham CR, Kappenberger LL, Abinader EG, Griffin JC, Falkoff MD. Implanted atrial pacemakers for paroxysmal atrial flutter. Long-Term efficacy. Ann Intern Med 1987;107:144-149
39. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344: 1523-1528
40. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Duran A, Val-Mejias J, Mackall J, Gold M. A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-633
41. Blanc JJ, De Roy L, Mansourati J, Poezevara Y, Marcon JL, SchoelsW, Hidden-Lucet F, Barnay C. Atrial pacing for prevention of atrial fibrillation: Assessment of simultaneously implemented algorithms. Europace 2004;6:371-379
42. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-129
43. Cox JL, Schuessler RB, D'Agostino HJ Jr, Stone CM, Chang BC, Cain ME, Corr PB, Boineau JP. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569-583
44. Damiano RJ Jr, Schwartz FH, Bailey MS, Maniar HS, Munfakh NA, Moon MR, Schuessler RB. The Cox maze IV procedure: Predictors of late recurrence. J Thorac Cardiovasc Surg 2011;141:113-121
45. Altmann DR, Knecht S, Sticherling C, Ammann P, Schaer B, Osswald S, Kuehne M. Treating AF with cryoballoon technology. J Atrial Fibrillation 2012;2:53-66. http:// www.jafib.com/published/webFormat/FullIssue/2012-04-14.pdf (14 January 2013
46. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-38
47. CalkinsH, Kuck KH, Cappato R, Brugada J, CammAJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606
48. Dang L, Virag N, Ihara Z, Jacquemet V, Vesin JM, Schlaepfer J, Ruchat P, Kappenberger L. Evaluation of ablation patterns using a biophysical model of atrial fibrillation. Ann Biomed Eng 2005;33:465-474
49. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T. A new approach for catheter ablation of atrial fibrillation: Mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004;43: 2044-2053
50. Verma A, Mantovan R, Macle L, De Martino G, Chen J, Morillo CA, Novak P, Calzolari V, Guerra PG, NairG, Torrecilla EG, Khaykin Y. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): A randomized, multicentre, international trial. Eur Heart J 2010;31:1344-1356
51. Kirchhof P, Breithardt G, Aliot E, al Khatib S, Apostolakis S, Auricchio A, Bailleul C, Benninger G, Blomstrom Lundqvist C, Boersma L, Boriani G, Brandes A, Brown H, Brueckmann M, Calkins H, Casadei B, Clemens A, Crijns H, Derwand R, Dobrev D, Ezekowitz M, Fetsch T, Gerth A, Gillis A, Gulizia M, Hack G, Haegeli L, Hatem S, Haeusler KG, Heidbuchel H, Hernandez-Brichis S, Jais P, Kappenberger L, Kautzner J, Kim S, Kuck K, Lane D, Leute A, Lewalter T, Meyer R, Mont Girbau L, Moses G, Mueller M, Muenzel F, Naebauer M, Nielsen JC, Oeff M, Oto A, Pieske B, Pisters R, Potpara T, Rasmussen L, Ravens U, Reiffel J, RIchard-Lordereau I, Schaefer H, Schotten U, Stegink W, Stein K, Steinbeck G, Szumowski L, Tavazzi L, Themistoclakis S, Thomitzek K, van Gelder IC, von Stritzky B, Vincent A, Werring DJ, WIllems S, Lip GYH, Camm AJ. Personalised management of atrial fibrillation: Proceedings from the 4th Atrial Fibrillation competence NETwork/European Heart Rhythm Association (AFNET/EHRA) consensus conference. Europace 2013; doi:10.1093/europace/eut232; in press